Drug Shortage Report for CISATRACURIUM OMEGA MULTIDOSE

Last updated on 2024-07-09 History
Report ID 213113
Drug Identification Number 02408813
Brand name CISATRACURIUM OMEGA MULTIDOSE
Common or Proper name Cisatracurium Besylate Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) CISATRACURIUM
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 x 10mL vial / fiole
ATC code M03AC
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-12-12
Estimated end date 2024-05-15
Actual end date 2024-04-01
Shortage status Resolved
Updated date 2024-07-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2024-07-09 English Compare
v12 2024-04-02 English Compare
v11 2024-04-01 French Compare
v10 2024-04-01 English Compare
v9 2024-02-20 English Compare
v8 2023-12-13 French Compare
v7 2023-12-13 English Compare
v6 2023-12-13 English Compare
v5 2023-12-12 French Compare
v4 2023-12-12 English Compare
v3 2023-12-12 French Compare
v2 2023-12-12 English Compare
v1 2023-12-12 English Compare

Showing 1 to 13 of 13